Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Melanoma has emerged as the fastest-growing malignancy in recent years, with incidence and mortality rates among both men and women in East Asian countries exceeding the Asian average. China ranks fifth among East Asian nations in melanoma incidence. Currently, immune checkpoint inhibitors are achieving significant breakthroughs in adjuvant melanoma therapy. This study aims to evaluate the efficacy and safety of sintilimab combined with chemotherapy versus chemotherapy alone in patients with PD-L1-positive, completely resectable mucosal melanoma, thereby providing additional clinical evidence for treatment decisions.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony czerniak błonisty wg badania histologicznego lub cytologicznego, z całkowicie usuniętymi guzami pierwotnymi i/lub przerzutami, bez śladów nowotworu na brzegach cięcia
- •Dodatni wynik testu PD-L1 w próbce tkanki
- •Wiek co najmniej 18 lat
- •Stan ogólny (wydolność) oceniony na 0 lub 1 w skali ECOG
- •Pierwsza dawka leku badanego podana najpóźniej 13 tygodni po operacji
- •Rana pooperacyjna całkowicie wygojona
- •Prawidłowe funkcje narządów i szpiku kostnego
- •Oczekiwana długość życia co najmniej 12 tygodni
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 3, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
The first hospital of Jilin University
Changchun, China
Trial contact
Di Wu, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.